导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.98% | 296/1050 |
| 近一周 | -2.01% | 407/1104 |
| 近一月 | -7.79% | 897/1102 |
| 近一季 | 16.69% | 43/1092 |
| 近半年 | -2.74% | 500/1070 |
| 近一年 | 2.95% | 513/1018 |
| 近两年 | 40.87% | 573/926 |
| 近三年 | -10.41% | 735/834 |
| 成立以来 | 181.11% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.56% 122/1070 |
-6.52% 833/1101 |
- - |
- - |
| 2025 | 3.88% 899/1065 |
2.96% 546/1014 |
-3.77% 921/1038 |
11.44% 828/1050 |
-5.92% 735/1065 |
| 2024 | -18.86% 893/1011 |
-11.40% 808/960 |
-14.97% 938/983 |
13.97% 305/991 |
-5.50% 696/1011 |
| 2023 | -13.67% 463/952 |
6.37% 240/880 |
-2.83% 361/895 |
-12.77% 713/915 |
-4.25% 427/952 |
| 2022 | -14.92% 169/867 |
-10.14% 109/773 |
7.32% 384/806 |
-7.92% 139/845 |
-4.18% 605/867 |
| 2021 | 20.51% 153/740 |
6.64% 36/580 |
7.57% 418/659 |
-2.40% 269/704 |
7.63% 131/740 |
| 2020 | 55.97% 212/554 |
7.76% 50/419 |
34.19% 77/466 |
12.16% 199/517 |
-3.83% 509/554 |
| 2019 | 81.60% 6/410 |
38.82% 75/1146 |
-5.23% 723/1228 |
24.12% 5/390 |
11.21% 126/410 |
| 2018 | -23.45% 124/349 |
- - |
-3.47% 151/990 |
-12.06% 868/1000 |
-14.93% 873/1080 |
| 2017 | 23.54% 71/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国泰大健康股票A VS. 东吴新产业精选股票A(580008) |